The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Clariscan 279.3 mg/ml solution for injection

279.3 milligram(s)/millilitre Solution for injection

GE Healthcare ASPA0735/011/001

Main Information

Trade NameClariscan 279.3 mg/ml solution for injection
Active SubstancesGadoteric acid
Strength279.3 milligram(s)/millilitre
Dosage FormSolution for injection
Licence HolderGE Healthcare AS
Licence NumberPA0735/011/001

Group Information

ATC CodeV08CA Paramagnetic contrast media
V08CA02 gadoteric acid

Status

Authorised/WithdrawnAuthorised
Licence Issued22/12/2017
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back